Nortis

Visit Nortis' website (click on the logo)

Nortis logo

Nortis logo

Board members

Thomas Neumann

Thomas Neumann

Chief Executive Officer

Ken Fisher

Ken Fisher

VP Operations

Short Description

Nortis is a biotech company with locations in Seattle and Woodinville, WA. Founded by former UW faculty and spun-out in 2012, Nortis has developed technologies for generating small segments of human tissues and organs in microfluidic chips for the in vitro study of human health and disease. The technology represents an alternative to lab animals in pharmaceutical drug development, where more predictive preclinical test models are urgently needed to increase clinical trial success. This advance will overcome a large barrier to developing therapeutic drugs and vaccines for diseases like cancer, diabetes, Alzheimer’s disease, infectious diseases, cardiovascular disease, and stroke.

Nortis location

Nortis location

Products

Nortis commercialized in 2015 a micro fluidic chip and its supporting perfusion platform. The chip allows the culture of several organs/tissue inside extracellular matrix.

aaa

Noticeable publications

– A human liver microphysiology platform for investigating physiology, drug safety, and disease models, Exp Biol Med, 2016

– Development of a microphysiological model of human kidney proximal tubule function, Kidney International, 2016

This is a unique website which will require a more modern browser to work! Please upgrade today!

Social Media Auto Publish Powered By : XYZScripts.com